Impact of Predilatation Between Self-expanding Valves
NCT04157920 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 78
Last updated 2023-12-26
Summary
A Multicenter, prospective, non-randomized, trial evaluating the safety and clinical efficacy of the next-generation, self-expandable Boston Scientific ACURATE NEO/TF Transcatheter Heart Valves, implanted in patients with severe aortic stenosis and the impact of predilatation in comparison with the Medtronic CoreValve EvolutT R/PRO systems from the DIRECT trial.
Conditions
- Aortic Stenosis
Interventions
- DEVICE
-
Transcatheter Aortic Valve Implantation with ACURATE NEO/TF
Transcatheter implantation of the heart valve device ACURATE neo/TF in patients suffering from severe aortic stenosis and are candidates for this operation
- DEVICE
-
Transcatheter Aortic Valve Implantation with Medtronic CoreValve /Evolut R/Pro
Transcatheter implantation of the heart valve device Medtronic Evolut R/Pro in patients suffering from severe aortic stenosis and are candidates for this operation
Sponsors & Collaborators
-
Naval Hospital, Athens
collaborator OTHER -
Silesian Centre for Heart Diseases
collaborator OTHER -
University General Hospital of Heraklion
collaborator OTHER -
Interbalkan Medical Center, Thessaloniki, Greece
collaborator UNKNOWN -
National and Kapodistrian University of Athens
lead OTHER
Principal Investigators
-
Konstantinos P Toutouzas, Professor · Professor of Cardiology
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-09-17
- Primary Completion
- 2021-04-01
- Completion
- 2022-07-20
Countries
- Greece
Study Locations
More Related Trials
-
A Clinical Evaluation of the HYDRA Self Expanding Transcatheter Aortic Valve
NCT02434263 ·Status: UNKNOWN ·Phase: NA
-
The TransCatheter Valve and Vessels Trial
NCT03424941 ·Status: COMPLETED ·Phase: NA
-
Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement
NCT01675440 ·Status: COMPLETED
-
accuRate Evaluation of Benefit With Optimal Medical Treatment With or Without Transcatheter Valve Repair of PARADOXical Low Flow Low Gradient Aortic Stenosis
NCT03863132 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of BAV in Different Hemodynamic Entities of Severe AS
NCT04053192 ·Status: COMPLETED
-
Bicuspid Valve Aortopathy Feasibility Study
NCT01920815 ·Status: COMPLETED
-
Feasibility, Safety, and Effectiveness of the ACURATE neo2 Transcatheter Heart Valve for Severe Bicuspid Aortic Stenosis
NCT06212050 ·Status: ENROLLING_BY_INVITATION
-
Progression of Ascending Aorta Diameters in Bicuspid Aortic Valve After Transcatheter or Surgical Replacement.
NCT05708118 ·Status: UNKNOWN
-
Transcatheter Aortic Valve Implantation Versus Standard Surgical Aortic Valve Replacement
NCT05261204 ·Status: ENROLLING_BY_INVITATION
-
Randomized Trial of TAVI vs. SAVR in Patients With Severe Aortic Valve Stenosis at Low to Intermediate Risk of Mortality
NCT03112980 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Prospective, Multicenter, Observational Study of the Safety and Efficacy of Emergency Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis
NCT07108478 ·Status: NOT_YET_RECRUITING
-
Safety and Efficacy Continued Access Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in Very High Risk Subjects and High Risk Subjects Who Need Aortic Valve Replacement
NCT01531374 ·Status: COMPLETED ·Phase: NA
-
ACURATE Neo™ TA Delivery System in Patient With Severe Aortic Stenosis
NCT02950428 ·Status: COMPLETED ·Phase: NA
-
Transapical Transcatheter Treatment Versus Conventional Surgery in Patients With Native Aortic Valve Stenosis
NCT00986193 ·Status: TERMINATED ·Phase: NA
-
Cerebrovascular EveNts in Patients Undergoing TranscathetER Aortic Valve Implantation With Balloon-expandable Valves Versus Self-expandable Valves.
NCT03588247 ·Status: COMPLETED
-
Changes of Ascending Aortic Diameter in Patients Undergoing Transcatheter Aortic Valve Replacement
NCT05739253 ·Status: RECRUITING
-
Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).
NCT01586910 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Transcatheter Aortic Valve Implantation Without Predilation
NCT01539746 ·Status: COMPLETED ·Phase: NA
-
DEFLECT I: Keystone Heart Embolic Deflection Trial
NCT01448421 ·Status: COMPLETED ·Phase: NA
-
Transcatheter Self-expandable Valve Implantation for the Treatment of Severe Native Aortic Regurgitation
NCT04864145 ·Status: RECRUITING ·Phase: NA
-
Alwide Plus China Post-market Clinical Investigation
NCT07304427 ·Status: COMPLETED
-
HLT transfemOral Replacement of aortIc Valve Via transcatherteriZatiON
NCT02157142 ·Status: COMPLETED ·Phase: NA
-
Sapien 3 Transcatheter Aortic Valve Replacement in Young Aortic Valve Stenosis Patients From China
NCT06830499 ·Status: RECRUITING
-
RanDOmized stUdy Comparing Both Latest Generation Self-Expanding Valves and a Minimalist approaCH vs. Standard Of Care In transCathEter Aortic Valve Implantation
NCT05036018 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Comparison of Transcatheter Heart Valves in High Risk Patients With Severe Aortic Stenosis: The CHOICE Trial
NCT01645202 ·Status: COMPLETED ·Phase: NA